Companies
AR
STOXX 600Health Care· Belgium
ARGX
Challengerargenx
$717.80
+1.01%
Open $708.40·Prev $710.60
as of 17 Apr
CHALLENGER
Power Core
argenx's moat is its proprietary FcRn biology platform, which enables systematic expansion across IgG-mediated autoimmune diseases from a single mechanism of action.
Published18 Apr 2026
UniverseSTOXX 600
SectorHealth Care
↑
Direction of Movement
upward
ROC 200
+48.3%
News
No recent news available.
Market data unavailable